pennyhotc's Blog

Crown Equity Holdings Inc. (CRWE.OB) announced that its subsidiary company, Crown Tele Services Inc. is still moving forward after dissolving its joint venture with Communication Expert Corporation and will gradually start rolling out its internet based voice and video service IP-PBX solutions next year.

The cornerstone of Crown Tele Services Inc. strategy is to meet the highest standards when it comes to delivering VoIP (Voice over Internet Protocol) communication solutions specifically designed to meet the market needs.

Commenting on the venture, Kenneth Bosket, president said, "We are still excited with this opportunity to expand our footprint in this valuable market. The demand for internet-based voice and video services is growing exponentially and our new subsidiary Crown Tele Services Inc. has launched its new website and intends to emerge as a service provider of choice."

According to ABI Research, the latest global business VoIP services forecasts show that the value of the overall market, which includes VoIP integrated access, SIP trunking, hosted IP-PBX/IP Centrex and managed IP-PBX services, is set to double over the next five years, to exceed $20 billion by 2015.

For more information about this company please visit www.crownequityholdings.com ,www.crownteleservices.com

****

Enzo Biochem, Inc. (NYSE:ENZ) has reported improved sequential results for the first fiscal quarter ended October 31, 2010, the result of recent programs to reduce expenses, consolidate activities and expand operations.

ENZ Total revenues for the first quarter of fiscal 2011 increased to $25.7 million, from $25.2 million a year ago, or 2%, despite slightly lower revenues at Life Sciences resulting from a program to emphasize higher margined products, and advanced 3% sequentially. Enzo Clinical Labs benefited from an increase in market share and a new provider contract.

Enzo Therapeutics, a biopharmaceutical subsidiary of Enzo Biochem (ENZ:NYSE), designs and develops enabling platforms based on immune and genetic regulation. These platforms offer multiple approaches for the treatment of a variety of diseases. The Company has focused its efforts in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases, and cancer. Many of the promising therapeutic applications currently under development are derived from pioneering work initiated at Enzo Life Sciences.

Enzo has concentrated its development on treatment regimens for diseases and conditions for which current treatment options are ineffective, costly, and/or cause unwanted side effects. Our focused efforts have generated a clinical and preclinical pipeline that is strongly supported by more than 40 patents and patent applications.

Enzo Therapeutics has established mutually rewarding, long-term relationships with academic institutions and enjoys a positive synergy with the Company's other two subsidiaries, Enzo Life Sciences and Enzo Clinical Labs.

For more information about this company please visit www.enzo.com

****

Eaton Vance Tax-Advantaged Glob (NYSE:ETG) reported the monthly distributions declared on the common shares of three of its closed-end equity funds (the "Funds"). The record date for the distributions is December 31, 2010, and the payable date is January 12, 2011. The ex-date is December 29, 2010. The declaration, record and payment dates of the regular January distribution have been accelerated to allow the Funds to meet their 2010 distribution requirements for federal excise tax purposes.

Eaton Vance Tax-Advantaged Global Dividend Income Fund (the Fund) is a diversified, closed-end management investment company. The Fund's investment objective is to provide after-tax total return consisting primarily of dividend income and capital appreciation.

****

SunAmerica Focused Alpha Growth (NYSE:FGI) announced the estimated amounts of the sources of the Fund's fourth quarterly dividend distribution of $0.05 per share of common stock declared on December 7, 2010 and payable on December 30, 2010 and the cumulative dividend distributions paid year-to-date. The following table sets forth the estimated amounts of the sources of the dividend distribution for purposes of Section 19 of the Investment Company Act of 1940, as amended (the "1940 Act") and the Rules adopted thereunder.

Sunamerica Focused Alpha Large-Cap Fund, Inc. is a close ended equity mutual fund launched and managed by SunAmerica Asset Management Corp. The fund is co-managed by BlackRock Investment Management and Marsico Capital Management, LLC. It invests in the public equity markets of the United States.

****

Eaton Vance Tax-Advantaged Bond (NYSE:EXD) reported important information concerning its distribution declared in December 2010. This information is issued as required by the Fund's managed distribution plan (Plan) and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of the Plan to make quarterly cash distributions to common shareholders, stated in terms of a fixed amount per common share. This information is sent to you for informational purposes only and is an estimate of the sources of the December distribution. It is not determinative of the tax character of the Fund's distributions for the 2010 calendar year.

Sign Up for our Free Stock Newsletter at http://www.pennyotcstock.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOtcStock.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOtcStock.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyotcstock.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

American Video Teleconferencing Corp. (AVOT.PK) reported that it is presently in final discussions to enter into a formal agreement to acquire an exclusive option on a molybdenum property in the Otter lake area in the province of Quebec, Canada. The property has been dormant since the 1960's when Hupon Mining and Exploration carried out surface work, stripping, trenching and a minor drill program of 445 feet contained in 11 drill holes. Some of the sample results from the trenching in 1962 showed 0.94% to 25% molybdenum averaging 5-10%. These values were obtained from assessment files in the Department of Mines in Quebec City.

This property is only one of several advanced stage properties the company has under consideration in the province of Quebec.

Molybdenum, is a Group 6 chemical element with the symbol Mo and atomic number 42. The free element, which is a silvery metal, has the sixth-highest melting point of any element. Molybdenum is very hard, but softer and more ductile than tungsten. Molybdenum has a high elastic modulus, and only tungsten and tantalum have higher melting points. Molybdenum is used to alloy many specialty steels. Some other common uses for molybdenum are electrodes, furnace applications, nuclear energy and missile and aircraft parts.

In addition, AVOT has hired a French speaking geologist to search the archives of the Quebec Department of Mines for Rare Earths showings. The company believes the rare earths industry is where it wants to maintain a very strong focus and is looking to expand its holdings.

The company will aggressively continue to search world-wide for opportunities in Precious, Base and Rare Earths metal projects.

****

Majestic Gold Corp. (TSX.V:MJS) (FSE:MJT) is a Vancouver-based; TSX Venture Exchange and Frankfurt Exchange listed gold exploration and development company with a very advanced gold deposit in Shandong province of China. On April 23, 2010, the company released an updated NI 43-101- compliant, indicated and inferred gold resource estimate on its Song Jiagou property. At present, Majestic Gold Corp. is aggressively pursuing a pre-feasibility study. A recently announced agreement will increase MJS.V's effective ownership from 54 to 94 % and has allowed the property to commence production at an initial rate of 1,400 tpd. With a contract that fixes operating costs and allows use of land and equipment, Majestic anticipates to have a positive cash flow, within a matter of months.

China has a long history of gold production. As early as 1091 BC, gold was legalized as money (as an alternative to silk), circulating in little squares. Hebei province, one of the main mining areas, claims production for over three thousand years. The Zhao Yuan mine in Shandong province has been worked for over a thousand years; other Shandong mines date from the 17th century.

After more than a century on the throne, South Africa has been deposed as the world's biggest producer of gold, with its estimated 2007 output, of 272 tonnes, falling just short of the 276 tonnes of the yellow metal produced by the new number one, China.

For more information about this company please visit http://www.majesticgold.net

****

AGIC International & Premium St (NYSE:NAI) announced they have declared the quarterly distributions. The dividends will be payable on January 7, 2011 to shareholders of record on December 31, 2010, with an ex-dividend date of December 29, 2010. NFJ's quarterly dividend was increased to $0.45 per share from $0.15 per share from the prior quarter. The dividend increase announced today by the Fund's Board of Trustees, based on the recommendation of the Fund's investment manager and sub-adviser, will bring the Fund's distribution rate (as a portion of net asset value per share) closer to that of its comparable domestic option strategy closed-end fund peers.

AGIC International & Premium Strategy Fund (the Fund), formerly Nicholas-Applegate International & Premium Strategy Fund, is a diversified, closed-end management investment company.

****

Blackrock Floating Rate Income (NYSE:FRA) reported January monthly distributions and special distributions. BlackRock Enhanced Government Fund, Inc. (NYSE:EGF) ("EGF") has adopted a level distribution plan (the "Plan") and employs either a managed distribution or an option over-write policy to support a level distribution of income, capital gains and/or return of capital. The fixed amounts distributed per share are subject to change at the discretion of EGF's Board.

BlackRock Floating Rate Income Strategies Fund, Inc. is a close ended fixed income mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC and BlackRock Financial Management, Inc.

****

Pimco Corporate Income Fund Com (NYSE:PCN) announced they have declared the following special year-end income dividends on the Funds are closed-end management investment companies. The primary objective of PCN is to seek high current income with secondary objectives of capital preservation and appreciation. The investment objective of PTY is to seek maximum total return through a combination of current income and capital appreciation. PFL and PFN's investment objective is to seek high current income, consistent with the preservation of capital.

PIMCO Corporate Income Fund is a close-ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. The fund is co-managed by Pacific Investment Management Company LLC.

Sign Up for our Free Stock Newsletter at http://www.pennyotcstock.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOtcStock.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOtcStock.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyotcstock.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty-five thousand dollars in cash from Majestic Gold Corp. (TSX Venture Exchange (TSX.V:MJS) and the Frankfurt Stock Exchange (FSE:MJT) for 30 (thirty) days of advertising, as well as for assistance in becoming a fully reporting publicly trading Bulletin Board company. Crown Equity Holdings Inc. (CRWE.OB) has received from the company 2,000,000 shares of (144) restricted common stock of American Video Teleconferencing Corp. (AVOT.PK) for 12 months IR Services and 1,000,000 shares of (144) restricted common stock for its IT services.

Proteonomix, Inc. (PROT.OB) previously reported that Ian McNiece has been appointed to the Proteonomix Board of Directors. Dr. McNiece, has served as Vice-President for Scientific Development and Chief Scientific Officer since November 11, 2009.

Mr. Michael Cohen, Chairman and CEO of Proteonomix, noted, ?The elevation of Dr. McNiece to the Board will allow Ian to play a greater role in developing corporate policy especially as it relates to the development and procurement of Intellectual policy (?IP?). Further, as BOD member, Dr. McNiece will have the ability to influence the development of other business strategies that affect the current portfolio of IP.?

Dr. McNiece stated, ?I look forward to serving on the Board of Directors and expediting the development and commercialization of our current and future products, especially as this relates to the Proteonomix portfolio of clinical applications.?

PROT is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging line of skin care products. StromaCel, Inc.?s goal is the development therapeutic modalities for the treatment of Cardiovascular Disease (CVD). StromaCel, Inc. is pursuing the licensing of other technologies for therapeutic use. National Stem Cell, Inc. is Proteonomix?s operating subsidiary. The Sperm Bank of New York, Inc. is a fully operational tissue bank. Proteonomix Regenerative Translational Medicine Institute, Inc. (?PRTMI?) intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Proteonomix intends to create and dedicate a subsidiary to each of its technologies.

For more information about this company please visit http://www.proteonomix.com

****

Global Hunter Corp. (TSX.V:BOB) (FSE:G5D) recently reported that it recently completed a surface sampling program at La Corona de Cobre. The program was designed to collect surface samples from the numerous prospective shear zones. This will aid in the definition of drill targets to expand on the copper oxide mineralization. The company has collected approximately 250 samples from the shear zones listed below.

The samples will be collected from outcrops along the entire strike lengths of the shears and have been shipped to ALS Chemex Labs in La Serena Chile for analysis. Results will be released as soon as practical after they have been received.

BOB.V focus is on strategic and base metals, particularly copper and molybdenum. The Company has built an outstanding portfolio of projects in the stable geopolitical geographies of Canada and Chile. Their exploration and development teams are on the ground rapidly advancing the La Corona de Cobre property near La Serena, Chile and the Rabbit South property in British Columbia, Canada. Either one of these projects could carry the company forward on a stand-alone basis, but together they bring the company additional stability, strength and value.

For more information about this company please visit http://www.globalhunter.ca/

****

International Game Technology (NYSE:IGT) Publishing and Diskeeper will appear on radio talk show Let?s Talk Computers. Que Publishing is a company of Pearson Education, the world?s largest education publisher and a Pearson (NYSE:PSO) company. Diskeeper Corporation is the undisputed leader in performance and reliability technologies.

International Game Technology (IGT) designs, manufactures, and markets electronic gaming equipment and systems products worldwide. Its systems products include applications for casino management, customer relationship marketing (CRM), and server-based player management.

****

Eaton Vance Tax-Managed Buy-Wri (NYSE:ETB) announced the earnings of the Fund for the three and nine months ended September 30, 2010. The Fund?s fiscal year ends on December 31, 2010.For the three months ended September 30, 2010, the Fund had net investment income of $1,033,036 ($0.042 per share). For the nine months ended September 30, 2010, the Fund had net investment income of $3,135,542 ($0.127 per share).

Eaton Vance Tax-Managed Buy-Write Income Fund is a closed-ended equity mutual fund launched and managed by Eaton Vance Management. It is co-managed by Parametric Portfolio Associates LLC and Rampart Investment Management Company, Inc.

****

Alliance New York Municipal Inc (NYSE:AYN) announced earnings for the Fund?s fourth fiscal quarter ended October 31, 2010.Total net assets of the Fund on October 31, 2010 were $111,905,530, as compared with $111,622,565 on July 31, 2010 and $110,415,698 on October 31, 2009. On October 31, 2010, the net asset value per share of common stock was $14.73 based on 4,827,532 shares of common stock outstanding.

Alliance New York Municipal Income Fund, Inc. operates as a nondiversified, closed-end management investment company. The fund invests primarily in municipal securities exempt from regular federal, New York State, and New York City income tax.

Sign Up for our Free Stock Newsletter at http://www.pennyotcstock.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOtcStock.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOtcStock.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyotcstock.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has previously received twenty thousand dollars in cash and twenty thousand dollars in free trading shares from a third party (Swiss Financial Report) for (30) days of advertisement services (which has expired) for Proteonomix, Inc. (PROT.OB) . Crown Equity Holdings Inc. (CRWE.OB) has received twenty-five thousand dollars in cash from Global Hunter Corp. (TSX Venture Exchange (TSX.V:BOB) and the Frankfurt Stock Exchange (FSE:G5D) for 30 (thirty) days of advertising, as well as for assistance in becoming a fully reporting publicly trading Bulletin Board company.

Golfsmith International Holdings Inc. (NASDAQ:GOLF) previously opened the company's most technologically advanced and interactive superstore, Golfsmith Xtreme. The new store will offer more products and more performance enhancing diagnostic equipment than any other Golfsmith location, and Friday and Saturday will feature more than $40,000 worth of prizes and giveaways.

Golfsmith International Holdings, Inc., through its subsidiary, Golfsmith International, Inc., operates as a specialty retailer of golf and tennis equipment, apparel, footwear, and accessories. Its stores offer branded clubs, balls, apparel, and accessories, as well as its proprietary-branded products, including Clubmaker, Golfsmith, Killer Bee, J.G.Hickory, Lynx, Profinity, Snake Eyes, TourTrek, XPC, Zevo, Maggie Lane, and ZTech. The company was founded in 1967 and is headquartered in Austin, Texas.

****

GreenHouse Holdings, Inc. (OTCQB:GRHU) has entered into a strategic partnership with ImageWare Systems, Inc. to provide sustainability and security products and services to government, military and law enforcement agencies, domestically and internationally.

GreenHouse's 1-Link service will now be part of the ImageWare Law Enforcement solution package that is being offered to over 20,000 law enforcement agencies in the United States. In turn, GreenHouse agreed to provide opportunities for IWS within the military and government markets for ImageWare biometric identity management solutions which will be included in the 1-Link platform along with other GreenHouse-offered products and services.

1-Link , in use today at the Center for Disease Control and Prevention (CDC) and the Commonwealth of Puerto Rico, integrates existing systems and provides enterprise-wide real-time access to data, voice, video, maps, incidents, management reports and resource information using existing infrastructure such as personal computers and mobile devices over TCP/IP, cellular and radio networks. 1-Link can integrate a single agency from the director to the field and can integrate multiple agencies. Each agency selects the information that agency will share securely within and across partner agencies. 1-Link is a scalable, modular, multi-lingual integrated platform for multiple agencies including healthcare systems, harbors, airports, police, fire, emergency medical services, emergency management agencies, education and other public and private agencies. For more information on 1-Link , please visit http://government.greenhouseintl.com/government/slider/1-link.

ImageWare Systems, Inc. is a leading developer of identity management solutions, providing biometric, secure credential and law enforcement technologies. Scalable for worldwide deployment, the Company's biometric product line includes a multi-biometric engine that is hardware and algorithm independent, enabling the enrollment and management of unlimited population sizes. ImageWare's identification products are used to manage and issue secure credentials including national IDs, passports, driver licenses, smart cards and access control credentials. ImageWare's digital booking products provide law enforcement with integrated mug shot, fingerprint Livescan and investigative capabilities. ImageWare is headquartered in San Diego, with offices in Portland, OR, Washington DC and Canada. For more information visit www.iwsinc.com.

GreenHouse Holdings, Inc. is a leading provider of energy efficiency solutions and sustainable infrastructure products. The Company designs, engineers and installs disparate products and technologies that produce persistent technical and financial results, by enabling their clients to monitor and control their energy costs in the most efficient manner possible. Their target markets for energy efficiency solutions include residential, commercial and industrial, as well as government and military markets. In addition, the Company develops, designs and constructs rapidly deployable, sustainable infrastructure primarily for use in disaster relief and security in austere regions.

For more information, go to http://www.greenhouseintl.com/ or the GreenHouse YouTube channel at http://www.youtube.com/greenhouseintl or follow GreenHouse on Twitter @greenhouseintl.

****

Magellan Petroleum Corporation (NASDAQ:MPET) received and accepted a legally binding commitment from its largest shareholder, Young Energy Prize s.a. (YEP), to provide the necessary funds required for MPET's wholly-owned Australian subsidiary to close out the acquisition from Santos Offshore Pty Ltd (Santos) of a 40% ownership interest in the Evans Shoal natural gas field in the Bonaparte Basin offshore Northern Territory Australia.

Magellan Petroleum Corporation and its subsidiaries engage in the exploration for, and development, production, and sale of oil and gas reserves in Australia, North America, and the United Kingdom. Its assets include the Mereenie, Palm Valley, and Dingo fields in Australia; the East Poplar and Northwest Poplar fields in Montana; and a series of licenses (Markwells Wood / Havant) in the onshore southern United Kingdom. The company was founded in 1957 and is based in Portland, Maine.

****

Douglas Lake Minerals Inc. (DLKM.OB) has filed a Canadian National Instrument 43-101 Standards for Disclosure of Mineral Projects ("NI 43-101) Technical Report (the "Technical Report") for its Handeni Project. Douglas Lake's 100% owned Handeni Project consists of four prospecting licenses covering approximately 800 square kilometers in the newly developing goldfields of Eastern Tanzania. Douglas Lake filed the Technical Report with the British Columbia Securities Commission via the System for Electronic Document Analysis and Retrieval (SEDAR).

The Technical Report was prepared by Dr. Reyno Scheepers, Ph.D., Pr.Sci.Nat., a South African based consulting geologist and a director of the Company who fulfills the requirements to be a 'Qualified Person' for the purposes of NI 43-101.

The Technical Report details the results of exploration activities conducted by IPP Resources, the previous holding company of the area. Extensive geophysical and geologic work was conducted over several field seasons from 2008. The work included prospecting, rock and soil sampling, and a ground magnetic survey. All geochemical analytical work was conducted by internationally accredited labs, SGS Laboratories and/or Humac Laboratories in Mwanza, Tanzania.

The exploration also included a fixed-wing aeromagnetic and radiometric survey. The survey and interpretation was conducted according to internationally accepted standards by the Council for Geoscience, South Africa. The Technical Report identified and selected a total of 12 priority gold targets which are recommended for follow up work.

Douglas Lake is an emerging mineral exploration company focused on exploring and developing mining opportunities in Tanzania.

For more information, go to http://www.douglaslakeminerals.com/.

****

Star Buffet Inc. (NASDAQ:STRZ) filed a Form 8-K with the Securities and Exchange Commission regarding two letters received from the NASDAQ Stock Market ("NASDAQ") on December 22, 2010. In the first letter, NASDAQ indicated that the Company was not in compliance with the NASDAQ Listing Rule 5250 (c) (1) for Continued Listing as a result of its failure to file its report on Form 10-Q for the period ended November 1, 2010. According to NASDAQ regulations, the Company has 60 calendar days from December 22, 2010 to submit a plan to regain compliance. Filing the Company's report on Form 10-Q for the quarter ending November 1, 2010 is the principal component of the plan.

Star Buffet is a multiconcept restaurant operator. As of December 28, 2010, Star Buffet, through its subsidiaries, operates seven 4B's restaurants, five JB's restaurants, five Barnhill's Buffet restaurants, four franchised HomeTown Buffets, three K-BOB'S Steakhouses, two Casa Bonita Mexican theme restaurants, two Whistle Junction restaurants, one BuddyFreddys restaurant, one Western Sizzlin restaurant, one Holiday House restaurant, one JJ North's Grand Buffet, one Pecos Diamond Steakhouse and one Bar-H Steakhouse.

Sign Up for our Free Stock Newsletter at http://www.pennyotcstock.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOtcStock.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOtcStock.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyotcstock.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received ten thousand dollars in cash and anticipates another ten thousand dollars in cash from the company for 60 days of advertisement services for Green House Holdings, Inc. (GRHU). In addition to the cash, Crown Equity Holdings Inc. (CRWE.OB) also anticipates receiving 20,000 shares of 144 restricted stocks from a third party.

Enzo Biochem, Inc. (NYSE:ENZ) is a growth-oriented integrated life sciences and biotechnology company focused on harnessing biological process to develop research tools, diagnostics and therapeutics, and serves as a provider of test services, including esoteric tests, to the medical community. Since our founding in 1976, our strategic focus has been on the development of enabling technologies in the life sciences field. Enzo Life Sciences develops, produces and markets proprietary labeling and detection products for gene sequencing, genetic analysis and immunological research, among others. Its catalog of over 30,000 products serves the molecular biology, drug discovery and pathology research markets worldwide.

Enzo Biochem reported improved sequential results for the first fiscal quarter ended October 31, 2010, the result of recent programs to reduce expenses, consolidate activities and expand operations.

Total revenues for the first quarter of fiscal 2011 increased to $25.7 million, from $25.2 million a year ago, or 2%, despite slightly lower revenues at Life Sciences resulting from a program to emphasize higher margined products, and advanced 3% sequentially. Enzo Clinical Labs benefited from an increase in market share and a new provider contract.

Gross profit margin improved 17% to $13.5 million, or 53% of revenues, compared to the fiscal 2010 fourth quarter's $11.5 million and was a slight improvement year over year. R&D expenses were $1.8 million, 28% lower than both a year ago and in the July 2010 quarter, and SG&A declined $0.5 million to $11.0 million, as a percentage of revenues down 3% from a year ago and 1% from the prior quarter. Overall operating expenses, including R&D, SG&A, legal and provision for uncollectible accounts were $14.6 million, a decline of 4% from last year's first quarter and 7% from the preceding July period. The operating loss decreased 42%, to ($1.1) million from the corresponding year-ago period, while the net loss of ($1.1) million was 38% lower year over year. EBITDA, adjusted for approximately $1.1 million in both periods for depreciation and amortization, was $23,000, compared to a year ago EBITDA loss of ($959,000), an improvement of $936,000.

Among the quarter's highlights (all references are to sequential quarter over quarter results, normalized for an inventory charge and severance of $1.8 million where applicable):

* Enzo Life Sciences, benefiting from increased emphasis on higher margin products, realized a greater than 100% gain in operating income.
* Enzo Clinical Labs increased revenues 6%, while reducing the operating loss 62%.
* Company-wide, gross margin increased $2.0 million or 17%.
* Operating expenses decreased 7%, or to 57% of revenues, from 63%.
* EBITDA, a non-GAAP measure, was $23,000, an improvement of $2.9 million from the prior quarter.
* Net loss for the quarter was reduced 70%.

About Enzo Life Sciences:

Enzo Life Sciences rapidly growing catalogue of over 8000 products, technologies and services is sold to scientists worldwide to "Enable Discovery in Life Sciences". The catalogue of products covers a wide area of science and used in research of DNA, Proteins and Cells. Our areas of focus include:

a) DNA, RNA and Protein Quantization Systems
b) Genomics and Molecular Biology
c) Labels and Probes
d) Research Assay Kits
e) Compound Libraries
f) Biochemicals, enzymes, proteins, and immunological in the fields.

More about ENZ at: www.enzo.com

****

Alzheimer's declines ultimately. Alzheimer's is a progressing sickness, in which symptoms gradually worsen over a period of time. Continuing, memory loss is minor, but with late-stage Alzheimer's, people will not be able to hold on a conversation and respond to their natural environment. Alzheimer's disease is the 6th major cause of loss of life in the USA. Some people that have Alzheimer's live life an average of eight years after their indications come to be noticeable to other people, but survival can range from 3 to 20 years, based on maturity and various health conditions.

Breast cancer (malignant breast neoplasm) is cancer from breast tissue, most frequently of your intrinsic lining of milk ducts as well as lobules that provide the ducts with milk. Cancers originating from ducts these are known as ductal carcinomas; those originating from lobules are classified as lobular carcinomas.

Parkinson's disease is actually a disorder that influences neurological cells, or neurons, found in a portion of the brain of which adjustments muscle motion. In Parkinson's, nerves that produce a chemical substance called dopamine die or don't work properly. Dopamine commonly delivers impulses that assist synchronize an individual's motions. No one knows what damages of these kind of cells. As signs and symptoms get worse, individuals with Parkinson's disease could have trouble walking, talking or doing simple tasks. They may also have problems such as depression, sleep problems or trouble chewing, swallowing or speaking.

Power3 Medical Products, Inc. (OTCBB:PWRM.OB) is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro , a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro , a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

Power3 Medical has announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer's and Parkinson's, to name a few.

In this case, Ira L. Goldknopf, President and Chief Scientific Officer of Power3 Medical Products, Inc., stated: "We are very excited to be finally ridding ourselves of litigation that has plagued us for several years now. We have big plans for the future beginning with our upcoming acquisition of Rozetta-Cell and are about to enter a long and substantial growth phase marked by advances in our science and intellectual property. Given the imminent nature of many of these transactions and breakthroughs, we have decided, in consultation with the financiers of Rozetta-Cell, that the best course of action for Power3 is to settle many of these lawsuits so that we can focus our attention exclusively on the acquisition of Rozetta-Cell and the development of our combined businesses after the merger."

Rozetta-Cell Life Sciences, Inc. is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company. The acquisition of Rozetta-Cell is expected to be completed in February 2011.

More about PWRM at: www.Power3Medical.com

****

Sign Up for our Free Stock Newsletter at http://www.pennyotcstock.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOtcStock.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOtcStock.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyotcstock.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Enzo Life Sciences:

Enzo Life Sciences is a leading manufacturer of high quality reagents, kits and products supplied to scientific researchers in academia, clinical research and drug discovery. With direct sales operations in US, Switzerland, Germany, UK, France and Benelux, Enzo Life Sciences also supports its 8000 products through a global network of dedicated distributors.

Enzo Life Sciences rapidly growing catalogue of over 8000 products, technologies and services is sold to scientists worldwide to "Enable Discovery in Life Sciences". The catalogue of products covers a wide area of science and used in research of DNA, Proteins and Cells. Our areas of focus include:

a) DNA, RNA and Protein Quantization Systems
b) Genomics and Molecular Biology
c) Labels and Probes
d) Research Assay Kits
e) Compound Libraries
f) Biochemicals, enzymes, proteins, and immunological in the fields.

More:

Enzo Biochem, Inc. (NYSE:ENZ) has reported improved sequential results for the first fiscal quarter ended October 31, 2010, the result of recent programs to reduce expenses, consolidate activities and expand operations.

Total revenues for the first quarter of fiscal 2011 increased to $25.7 million, from $25.2 million a year ago, or 2%, despite slightly lower revenues at Life Sciences resulting from a program to emphasize higher margined products, and advanced 3% sequentially. Enzo Clinical Labs benefited from an increase in market share and a new provider contract.

Enzo Biochem is a growth-oriented integrated life sciences and biotechnology company focused on harnessing biological process to develop research tools, diagnostics and therapeutics, and serves as a provider of test services, including esoteric tests, to the medical community. Since our founding in 1976, our strategic focus has been on the development of enabling technologies in the life sciences field. Enzo Life Sciences develops, produces and markets proprietary labeling and detection products for gene sequencing, genetic analysis and immunological research, among others. Its catalog of over 30,000 products serves the molecular biology, drug discovery and pathology research markets worldwide.

More about ENZ at: www.enzo.com

****

Semtech Corp. (Nasdaq:SMTC) announced it has entered into an agreement in principle to settle all claims asserted against all defendants in the putative class action concerning the Company's stock option accounting practices captioned In re Semtech Corporation Securities Litigation, Case No. 2:07-cv-07114-CAS (C.D. Cal). The agreement in principle provides for the payment of $20 million by the Company. The agreement in principle contemplates the negotiation and execution of a final settlement agreement.

Semtech Corporation, together with its subsidiaries, engages in the design, development, manufacture, and marketing of analog and mixed-signal semiconductor products.

****

Insituform Technologies Inc. (Nasdaq:INSU) announced that its Indian joint venture, Insituform Pipeline Rehabilitation Private Limited ("Insituform-India"), has been awarded a contract valued at US $5.6 million to rehabilitate approximately 16,000 feet of medium diameter sewer pipelines for the Indian water utility Uttar Pradesh Jal Nigam, located in Northern India approximately 400 miles Southeast of New Delhi. This contract strengthens Insituform-India's position in the Indian market with the expansion into Uttar Pradesh. This project marks the first contract for Insituform-India outside Delhi, where Insituform-India has been awarded approximately $42.0 million in work to date.

Insituform Technologies, Inc., through its subsidiaries, provides proprietary technologies and services for rehabilitating sewer, water, energy, and mining piping systems and the corrosion protection.

****

Gentiva Health Services Inc. (Nasdaq:GTIV) a leading provider of home health and hospice services, announced that it will present at the J.P. Morgan 29th Annual Healthcare Conference 2011 in San Francisco at 9:30 a.m. PT (12:30 p.m. ET) on Thursday, January 13, 2011. The presentation will be available to the public via live audio webcasts, which may be accessed. Visitors to this site will also be able to request advance notifications of these or other upcoming Gentiva events.

Gentiva Health Services, Inc. provides home health services in the United States. The company offers skilled nursing and therapy services, paraprofessional nursing services, and homemaker services primarily to adult and elderly patients through licensed and Medicare-certified agencies.

****

Douglas Lake Minerals Inc. (the "Company" or "Douglas Lake") (OTCBB:DLKM.OB) has announced that the Commissioner for Minerals of Tanzania has confirmed the recording in the Central Register the transfer of 100% shares of each of the Prospecting License Nos. 6742/2010, 6743/2010, 6744/2010 and 6779/2010 from IPP Gold Limited to Douglas Lake Minerals Inc., and that such transfer has been duly recorded on the terms and conditions contained in such Prospecting Licenses. These Prospecting Licenses, which cover an area of approximately 800 square kilometers, form Douglas Lake's recently acquired Handeni Project.

More:

Douglas Lake Minerals Inc. has provided an update regarding its recently acquired Handeni Project which is located in the rapidly developing region of eastern Tanzania. Douglas Lakes' 100% owned Handeni Project consists of four prospecting licenses covering approximately 800 km(2) which are directly adjacent to, and partly surround, Canaco Resources Inc's (V.CAN) 200 km(2) Kilindi license which holds the Magambazi gold mineralization occurrence.

Douglas Lake Successfully Delineates Structural Controls on Gold Mineralization in the Four Handeni Project PLs.

DLKM is an emerging mineral exploration company focused on exploring mining opportunities in Tanzania. The Company offers gold mining and exploration services. The company is based in Surrey, Canada.

More about DLKM at: www.douglaslakeminerals.com

****

Sign Up for our Free Stock Newsletter at http://www.pennyotcstock.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOtcStock.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOtcStock.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyotcstock.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Rare earth elements have become irreplaceable in clean tech, for instance in hybrid and electric vehicle motors, high-efficiency lamps, solar panels and wind turbines. They even play a key role in defense technologies which include cruise missiles, radar and sonar and precision-guided weapons.

Experts warn that the U.S. depends upon China for almost all of its supply of rare earths, and has let its own rare earth production languish despite possessing about 15 % of the world's reserves. A draft of a Chinese rare earths plan for 2009-2015 expresses that China's own industrial requirement could soon cause restrictions or bans on the export of rare earths.

The U.S. Geological Survey (USGS) noted that 91 % of U.S. usage of rare earths originated in China between 2005 and 2008.

Constraints on Chinese exports are creating opportunities for non-Chinese projects.

More:

American Video Teleconferencing Corp. (Pink Sheets:AVOT.PK), "the company", has announced that it is presently in final discussions to enter into a formal agreement to acquire an exclusive option on a molybdenum property in the Otter lake area in the province of Quebec, Canada. The property has been dormant since the 1960's when Hupon Mining and Exploration carried out surface work, stripping, trenching and a minor drill program of 445 feet contained in 11 drill holes. Some of the sample results from the trenching in 1962 showed 0.94% to 25% molybdenum averaging 5-10%. These values were obtained from assessment files in the Department of Mines in Quebec City.

This property is only one of several advanced stage properties the company has under consideration in the province of Quebec.

To contact the company, Email at dealseekers10@gmail.com

****

Sterling Financial Corp. (Nasdaq:STSA) announced that it has entered into an amendment to its Shareholder Rights Plan designed to preserve substantial tax assets. The amendment extends the expiration of the Rights Plan until August 26, 2013. Sterling's Board of Directors originally adopted the Rights Plan on April 14, 2010 and has concluded that extending the Rights Plan is in the best interests of Sterling and its shareholders. The plan is similar to tax benefit preservation plans adopted by other public companies with significant tax attributes. Sterling's tax attributes include net operating losses, capital losses and certain built-in losses that it could utilize in certain circumstances to offset taxable income and reduce its federal income tax liability.

Sterling Financial Corporation operates as the bank holding company for Sterling Savings Bank that provides various banking products and services to small and medium-sized businesses, and individuals.

****

CRA International Inc (Nasdaq:CRAI) announced its role in providing accounting analysis and testimony in two matters related to mutual fund fees that went before the US Supreme Court. On December 9, 2010, the United States District Court of Minnesota reinstated summary judgment in favor of Ameriprise in Gallus v. Ameriprise Financial, Inc., a lawsuit related to mutual fund fees. In this matter, the Plaintiffs purchased American Express mutual funds and alleged that the Defendants, as investment advisers, charged excessive fees in violation of Section 36(b) of the Investment Company Act of 1940.

CRA International, Inc. operates as a consulting firm that provides economic, financial, and business management consulting expertise worldwide.

****

Talecris Biotherapeutics Holdings Corp. (Nasdaq:TLCR) announced that a jury in the General Court of Justice, Superior Court Division, Wake County, North Carolina, rendered a verdict on December 13, 2010 in the amount of $37 million in favor of Plasma Centers of America, LLC, against its subsidiary, Talecris Plasma Resources, Inc., in a breach of contract claim. Talecris had a three-year Plasma Sale/Purchase Agreement with Plasma Centers of America under which Talecris was required to purchase plasma from plasma collection centers built by Plasma Centers of America and approved by Talecris.

Talecris Biotherapeutics Holdings Corp., a biopharmaceutical company, engages in the production and marketing of plasma-derived protein therapies worldwide.

****

Enzo Biochem, Inc. (NYSE:ENZ) has reported improved sequential results for the first fiscal quarter ended October 31, 2010, the result of recent programs to reduce expenses, consolidate activities and expand operations.

Total revenues for the first quarter of fiscal 2011 increased to $25.7 million, from $25.2 million a year ago, or 2%, despite slightly lower revenues at Life Sciences resulting from a program to emphasize higher margined products, and advanced 3% sequentially. Enzo Clinical Labs benefited from an increase in market share and a new provider contract.

Among the quarter's highlights (all references are to sequential quarter over quarter results, normalized for an inventory charge and severance of $1.8 million where applicable):

* Enzo Life Sciences, benefiting from increased emphasis on higher margin products, realized a greater than 100% gain in operating income.
* Enzo Clinical Labs increased revenues 6%, while reducing the operating loss 62%.
* Company-wide, gross margin increased $2.0 million or 17%.
* Operating expenses decreased 7%, or to 57% of revenues, from 63%.
* EBITDA, a non-GAAP measure, was $23,000, an improvement of $2.9 million from the prior quarter.
* Net loss for the quarter was reduced 70%.

About Enzo Biochem:

ENZ is a growth-oriented integrated life sciences and biotechnology company focused on harnessing biological process to develop research tools, diagnostics and therapeutics, and serves as a provider of test services, including esoteric tests, to the medical community. Since our founding in 1976, our strategic focus has been on the development of enabling technologies in the life sciences field. Enzo Life Sciences develops, produces and markets proprietary labeling and detection products for gene sequencing, genetic analysis and immunological research, among others. Its catalog of over 30,000 products serves the molecular biology, drug discovery and pathology research markets worldwide.

More about ENZ at: www.enzo.com

****

Sign Up for our Free Stock Newsletter at http://www.pennyotcstock.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOtcStock.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOtcStock.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyotcstock.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received from the company 2,000,000 shares of (144) restricted common stock of American Video Teleconferencing Corp. (AVOT.PK) for 12 months IR Services and 1,000,000 shares of (144) restricted common stock for its IT services.